Skip to main content
OpenTrials

Clinical trial condition

Anus Neoplasms

Explore clinical trials studying Anus Neoplasms. Study availability and eligibility vary by location and protocol.

222 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Anus Neoplasms trial results

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations
  • University of Arizona, VA Medical Center Tucson, Arizona, United States
  • Detroit Medical Center, Wayne State University Detroit, Michigan, United States
  • East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States
  • University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

NCT04166318

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 659 locations
View Trial Details
Active, Not Recruiting

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

NCT04444921

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +18 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 580 locations
View Trial Details
Active, Not Recruiting

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

NCT03233711

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 897 locations
View Trial Details

Related conditions